PBPH vs VYM

PBPH vs VYM

Which is better, PBPH or VYM?

Large Cap Blend against Large Cap Value.

VYM has a lower expense ratio. VYM is less concentrated, with 26.1% of the fund in its ten largest positions against 61.8%.

Lower Fees: VYMLess Concentrated: VYM

MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.

Side-by-Side Comparison

MetricPBPHVYM
Expense Ratio0.13%0.04%Best
AUM$1.0B$81.6B
Dividend Yield0.08%2.22%
Holdings57613
YTD Return+12.09%Best+11.35%
1Y Return-+15.34%
3Y Return (annualized)-+17.22%
5Y Return (annualized)-+12.30%
Top 10 Weight61.8%26.1%Best
Fund FamilyPortfolio Building Block ETFsVanguard (US)
CategoryEquityEquity
StyleLarge Cap BlendLarge Cap Value
InceptionNov 24, 2025Nov 10, 2006

Not shown on this pair: Volatility (annualized), Max Drawdown, $10,000 over the window.

PBPH vs VYM growth

Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view is available from the range buttons; it is not the opening view here because over the whole period one of these two funds moves so much further than the other that its line would sit flat on the axis.

PBPH vs VYM Performance

Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is an ETF from Portfolio Building Block ETFs and Vanguard High Dividend Yield ETF (VYM) is an ETF from Vanguard (US). Year to date, PBPH is up 12.09% versus a gain of 11.35% for VYM.

Past performance does not guarantee future results.

Fees and Cost Over Time

PBPH charges 0.13% per year while VYM charges 0.04%. On a $10,000 position that is $13 vs $4 annually, a gap of $9 per year that compounds over a long holding period. On income, PBPH currently yields 0.08% against 2.22% for VYM.

Holdings Overlap

PBPH already in VYM38.0%
VYM already in PBPH8.4%

38.0% of PBPH's money is in holdings VYM also owns. 8.4% of VYM's money is in holdings PBPH also owns.

The two portfolios partly overlap.

9 positions in common, counted across the 53 positions we hold weights for in PBPH and 557 in VYM, against full books of 57 and 613.

What only one of them owns

Our book lists 519 positions for VYM that do not appear in our book for PBPH (88.7% of the fund), and 20 for PBPH that do not appear in VYM (28.6%).

Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.

Top Shared Holdings

StockWeight in PBPHWeight in VYMDifference
JNJJohnson & Johnson - Common9.76%2.51%7.25%
ABBVAbbvie Inc.6.85%1.80%5.05%
MRKMerck & Company Inc5.00%1.31%3.69%
AMGNAmgen Inc.4.89%0.78%4.11%
GILDGilead Sciences3.97%0.66%3.31%
PFEPfizer Inc3.46%0.58%2.88%
BMYBristol-Myers Squibb Co.3.01%0.54%2.47%
ZTSZoetis Inc, Class A0.69%0.13%0.56%
VTRSViatris Inc.0.42%0.08%0.34%

38.0% of PBPH is already inside VYM.

You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.

PBPHVYM

Free for up to 10 holdings. No account needed.

Frequently Asked Questions

Which is cheaper, PBPH or VYM?

PBPH has an expense ratio of 0.13% while VYM charges 0.04%. VYM is the cheaper option, by $9 a year on a $10,000 investment.

What is the holdings overlap between PBPH and VYM?

38.0% of PBPH's money is in holdings VYM also owns. 8.4% of VYM's is in holdings PBPH also owns. They hold 9 positions in common, counted across the 53 positions we hold weights for in PBPH and 557 in VYM.

Which pays a higher dividend, PBPH or VYM?

PBPH yields 0.08% while VYM yields 2.22%, so VYM currently pays the higher dividend yield.

Is VYM better than PBPH?

VYM has a lower expense ratio. VYM is less concentrated, with 26.1% of the fund in its ten largest positions against 61.8%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.